Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: A Rare Mimic of Giant Cell Arteritis

Iryna Nemesh, MD, Saleema Kherani, MD MPH, Shikha Singla, MD, & William Wirostko, MD  |  Issue: November 2021  |  November 14, 2021

Syphilis is a chronic sexually transmitted disease (STD) caused by the spirochete Treponema pallidum. The clinical manifestations of syphilis are divided into four stages: 1) the primary stage, characterized by painless mucosal or cutaneous chancre at the site of infection that resolves spontaneously; 2) the secondary stage in which a generalized maculopapular rash and condyloma lata are the most characteristic manifestations; 3) the latent stage, which represents a clinically undetectable period; and 4) the tertiary stage, which develops in untreated patients, can affect up to 15–40% of patients and manifests with cardiovascular and neurologic involvement.

Ocular syphilis, previously thought to be uncommon, has drawn renewed interest due to an increase in the number of cases. The incidence has dramatically increased in the U.S. since the early 2000s with re-emergence of syphilis among homo­sexual males and drug users with concurrent HIV infection.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The challenge of ocular syphilis is that it can manifest in a number of different ways, with posterior uveitis being the most common.2 Other common manifestations include interstitial keratitis, recurrent anterior uveitis, retinal vasculitis and optic neuropathy.3 Ocular symptoms can occur as early as six weeks after transmission, and it may often be the only presenting feature of systemic syphilis. Patients usually present with complaints of blurry vision and are at risk of permanent blindness if left untreated.

Patients with large vessel vasculitis, such as giant cell arteritis (GCA), can present with a spectrum of vision changes. Sudden monocular visual loss, particularly in an older adult, from arteritic anterior ischemic optic neuropathy (AAION) is a feared complication of GCA because it can lead to complete visual loss.4

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Our case highlights some of the similarities between these two conditions.

Case Report

A 76-year-old man with a past medical history of coronary artery disease and hyperlipidemia presented to the ophthalmology clinic with acute blurring of vision in the right eye. He had been noticing a black spot in the center of the visual field of the eye for about four days prior to presentation. He also reported distortion of his vision, as well as an inability to read out of the right eye.

Along with the visual changes, the patient reported a sharp pain in the right temple area that had occurred around the same time. He described having right posterior and occipital scalp sensitivity intermittently for the previous year, although he said the pain in the temple was new.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:ocular diseasesyphilis

Related Articles

    Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection

    March 1, 2013

    Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously

    Atypical Giant Cell Arteritis Case Illustrates Diagnosis, Management Challenges

    Atypical Giant Cell Arteritis Case Illustrates Diagnosis, Management Challenges

    November 14, 2021

    Giant cell arteritis (GCA) is a granulomatous vasculitis of large- and medium-sized arteries, usually affecting the cranial branches of the aortic arch. It is the most common vasculitis, with the highest risk factor being age. Accurate diagnosis and prompt initiation of therapy are of great importance to prevent serious complications, with the most feared being…

    Experts Discuss Proposed Giant Cell Arteritis Risk Tool

    April 26, 2018

    A proposed model to predict the risk of giant cell arteritis (GCA) prior to a temporal artery biopsy could help triage patients and guide decision making about the need for biopsy or monitoring (see Figure 1). There’s no specific biomarker for GCA, and GCA can be a “diagnostic conundrum, especially when it presents in an…

    Updates on Giant Cell Arteritis

    March 19, 2018

    SAN DIEGO—Recent research tells us more about giant cell arteritis (GCA) to help rheumatologists more accurately diagnose and effectively treat patients with this type of vasculitis. On Nov. 6 at the ACR/ARHP Annual Meeting, three experts explored the latest findings on GCA pathogenesis, diagnostic approaches, imaging modalities and growing treatment options. GCA: What’s Really Happening?…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences